|
|
||||||||
1 Integrated Graduate Program in the Life Sciences, Northwestern University Medical School, Chicago, Illinois 60611; 2 Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana 46202; and 3 Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131
| |
ABSTRACT |
|---|
|
|
|---|
The
microvascular wall is remarkably simple, consisting only of the
endothelial lining, subjacent basal lamina, and underlying periendothelial cells. This study describes the
characterization of a novel microvascular protein. This
80,000-molecular weight protein was predominantly associated with
electron-lucent amorphous material in capillary basal laminae and
therefore termed cablin (protein of the capillary basal lamina).
Consistent with its immunolocalization to the microvasculature, cablin
was synthesized and secreted by cultured endothelial cells and vascular
smooth muscle cells. Furthermore, cablin expression was induced during
neovascularization. The predicted amino acid sequence of cablin
revealed a prevalence of polar amino acids. Accounting for the low yet
significant homology to several
-helical proteins, these residues
were best accommodated by secondary structure predictions that aligned
the molecule into two large
-helical domains. The presence of the
integrin-binding RGD tripeptide and a putative elastin-binding sequence
suggest that this rodlike molecule is suited to cross-link cells and
matrix constituents. In this capacity it could contribute to the
mechanical strength or the angiogenic potential of the microvasculature.
vascular smooth muscle; endothelial cell; microvascular; extracellular matrix
| |
INTRODUCTION |
|---|
|
|
|---|
BY VIRTUE of their unique ultrastructure, microvascular beds, composed of precapillary arterioles, capillaries, and postcapillary venules, are the principal sites of neovascularization (7, 24) and molecular exchange between the blood and the interstitial fluid (47). Because capillaries lack both a muscular wall and elaborate elastic subendothelial layers, the walls of these vessels consist only of the single layer of endothelial cells lining the lumen and a minimal subendothelial basal lamina (15). It is this basal lamina and surrounding periendothelial cells that provide the capillary with mechanical support (48). Microvascular beds such as the renal glomerular capillaries are especially dependent on the subendothelial basal lamina for tensile strength due to the high hydrostatic pressure experienced during the formation of plasma filtrate (10). Organized immediately subjacent to the capillary endothelium, the basal lamina consists of a meshwork of molecules that ensheath the endothelial and periendothelial cells (46). The intimate association among endothelium, basal lamina, and periendothelium facilitates rapid transport of molecules and provides a means of intercellular and intrasystemic communication.
Endothelial and periendothelial cells are the primary cellular constituents of the microvasculature. The continuous endothelial cell lining of the capillary lumen acts as the primary selective barrier, the tightness of which directly affects vessel wall permeability (43). Subsequently, capillary periendothelial cells ("pericytes") together with the basal lamina act as a molecular sieve that limits access to the interstitium (6). Pericytes and capillary endothelial cells act in concert to secrete and organize the basal lamina that forms such an integral component of capillary architecture (8, 13, 20, 23, 27, 30, 53, 55, 57).
Microvascular basal laminae, similar to those of larger muscular and
elastic vessels, consist of a heterogeneous network of extracellular
matrix proteoglycans and proteins. These molecules are integral
components of the vascular architecture as well as regulators of
cellular processes. Among the most thoroughly characterized capillary
basal laminae are the renal glomerular basement membrane and the
juxtaglomerular mesangial matrix (5, 14, 33, 40). A prominent
constituent of these and other vascular matrices are the microfibrils,
morphologically unique 10- to 12-nm diameter fibers (34) that occupy an
amorphous, electron-lucent basal lamina region (7, 24). The necessity
for properly assembled microfibrils is punctuated by the incidence of
diseases in which a single allele of a microfibrillar component is
mutated. Such disorders include Marfan's syndrome and congenital
contractural arachnodactyly and are manifested as vascular and
connective tissue abnormalities (12, 45). Microfibrils may also
function as a repository for soluble effectors. For example, latent
transforming growth factor-
(TGF-
) binding proteins are
associated with microfibrils, where TGF-
may be stored before
activation (21, 38, 42). Likewise, the clotting factor thrombospondin
has been localized to microfibrils in the vascular basement membrane,
where it may mediate thrombogenesis in response to vascular injury (3). A subset of capillary basal lamina proteins bind select cell-surface integrins, thereby mediating cell-extracellular matrix adhesion (9-11). Integrins are heterodimeric, membrane-spanning receptors that serve as a molecular interface between the extra- and
intracellular environment (2). Intracellularly, activation of signaling
cascades in response to integrin ligation serves to modulate cell
motility, gene expression, and differentiation state (29).
Extracellularly, integrins impact adhesion to components of the
extracellular milieu in response to cellular cues (29). It is precisely
this biochemical complexity of capillary basal laminae that underlies
their vital functions in structural support, cell-extracellular matrix
interactions, and metabolite exchange.
The extracellular matrix also serves as a source of cues promoting angiogenesis and differentiation of the microvasculature. The spatiotemporal regulation of angiogenesis from existing capillary vessels is dependent on changes in the composition and organization of the extracellular matrix (51). The presence of appropriate growth factors and extracellular matrix constituents dictate both capillary sprouting and endothelial migration through the activation of discrete signaling cascades (50, 54). Until needed, some of these growth factors are maintained in an inactive state by sequestration within matrices. For example, following capillary injury fibroblast growth factor is immediately released from proteoglycans to potentiate angiogenesis and promote rapid wound healing (16). Capillary endothelial cells undergoing angiogenic migration secrete both extracellular matrix proteins and chemoattractants (51). These molecules in turn elicit the recruitment of interstitial fibroblasts and their subsequent differentiation into pericytes (49, 50). Given the developing scenario it is tempting to postulate that the cells comprising capillaries are expressly adapted to the synthesis of a unique basal lamina that supports both molecular exchange and angiogenesis.
Vascular transitions to and from the highly anastomosing capillary beds are delineated by gradual modulations in vessel architecture and cellular phenotype (19, 47). The diversity of endothelial and periendothelial cells along the vasculature is thought to represent a continuum of cellular differentiation states (49), as well as heterogeneity brought about by local demands (51). The recent discovery of proteins expressed exclusively by either venous or arterial endothelial cells, considered together with the morphological diversity of these cells, provides evidence of genetically determined distinctions between the cellular constituents of the circulation (1, 59). The interdependence between cellular differentiation and extracellular matrix constituents makes it plausible that the observed biochemical and morphological gradations are accompanied by changes in the molecular composition of microvascular basal laminae. Whereas the inventory of the microfibrillar and integrin-binding extracellular matrix proteins found in the basal laminae of capillaries and other vessels continues to grow, it is still incomplete. Furthermore, the identification of those molecular constituents selectively enriched in the microvascular wall remains a challenge. This study describes the first such candidate, a novel protein preferentially expressed in microvascular extracellular matrices.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Reagents. Sodium dodecylsulfate, Triton X-100, Tween 20, AEBSF [4-(2-aminoethyl)benzenesulfonylfluoride, HCl], and Mowiol were obtained from Calbiochem (San Diego, CA). Affigel-10 activated resin was obtained from Bio-Rad (Hercules, CA). Horseradish peroxidase (HRP)-conjugated secondary antibodies and nitrocellulose membranes were supplied by Amersham (Arlington Heights, IL). Super Signal ECL was purchased from Pierce (Rockford, IL). FITC- and rhodamine-conjugated donkey anti-rabbit IgG, goat anti-mouse IgG, and alkaline phosphatase-conjugated goat anti-rabbit IgG were supplied by Jackson ImmunoResearch (West Grove, PA). Gold-conjugated (20 nm) goat anti-rabbit IgG, LR White embedding resin, uranyl acetate, lead citrate, and nickel grids were purchased from Ted Pella (Redding, CA). A mouse monoclonal antibody (A028) directed against an endothelial cell surface marker was obtained from Telios Pharmaceuticals (San Diego, CA) in the form of ascites. All other chemicals and reagents were purchased from Sigma (St. Louis, MO).
Isolation and characterization of
cDNA. An oligo(dT)-primed
-ZAP human placental cDNA
library (3 × 1010
independent clones) was obtained from Stratagene (La Jolla, CA). The
library was plated onto Escherichia
coli XL-1 Blue (Stratagene) lawns and grown at 42°C
for 3.5 h. Nitrocellulose filters impregnated with 10 mM
isopropylthio-
-D-galactopyranoside
were applied to the agar plates and incubated at 37°C for an
additional 3.5 h. The filters were removed and washed in Tris-buffered
saline (TBS, 50 mM Tris · HCl, pH 8.0, 200 mM NaCl),
and nonspecific binding sites were blocked for 1 h with TBS-T (TBS,
0.1% Tween 20) containing 0.2% newborn calf serum.
Antiserum directed against a unique peptide (AVWPTRTQGPLPSSLGK) or
affinity-purified antipeptide antibodies (preadsorbed against
E. coli lysate) were diluted in TBS-T
containing 0.2% newborn calf serum and incubated with the membranes
for 30 min at room temperature under continuous agitation. The
membranes were washed five times with TBS-T (5 min each) at room
temperature. After the washes, the membranes were incubated with
alkaline phosphatase-conjugated goat anti-rabbit IgG diluted in TBS-T
containing 0.2% newborn calf serum for 30 min at room temperature.
After being washed with TBS-T (five times, 5 min each), positive
plaques were identified using nitroblue tetrazolium (0.05%) and
bromo-chloro-indolylphosphate (0.015%) in TBS. Membranes were aligned
with the agar plates and positive plaques were isolated by suspending
core samples from the agar plates in 1 ml of 50 mM
Tris · HCl, pH 7.5, containing 100 mM NaCl, 2 mM
MgSO4, 0.01% gelatin, and 3%
chloroform. XL-1 Blue cells were grown to
OD600 = 1.0, mixed with isolated
Bluescript phagemid stock and ExAssist helper phage (Stratagene). The
cells were incubated for 15 min at 37°C, additional media were
added to the infected cells, and the mixture was incubated at 37°C
for an additional 2 h. Cells were pelleted by centrifugation for 15 min
at 2,000 g. The supernatant was
collected, heated at 70°C, and cleared by centrifugation for 15 min
at 4,000 g. The supernatant containing
filamentous phage was collected and used to infect E. coli strain SOLR cells (Stratagene). Isolated colonies
were selected on ampicillin plates, and plasmids were isolated with the
QIAprep Miniprep kit (Qiagen, Valencia, CA).
Plasmid inserts were sequenced using the GIBCO BRL Life Technologies
(Gaithersburg, MD) cycle sequencing kit. Sequence analysis of all
isolated clones resulted in the identification of 10 cDNA clones, 4 of
which were identical (termed c4) and chosen for sequence analysis.
Sequencing primers were supplied by Operon (Alameda, CA). Forward
primers corresponded to T3 promotor sequences contained within
pBluescript (5'-AATTAACCCTCACTAAAGGG-3') and bases
166-193, 375-394, and 444-466 of the c4 cDNA. Reverse
primers corresponded to T7 promotor sequences contained within
pBluescript (5'-GTAATACGACTCACTATAGGGC-3') and bases
1550-1567 of the c4 cDNA. PCR constructs encoding central portions
of the c4 cDNA (either from bases 444-1567 or from bases 580-1176) were used to sequence these regions using the T3 and T7
primers (see above). Primers were end-labeled using T4 kinase with
[
-33P]ATP (2-4
Ci/mol) (NEN Life Sciences Products, Boston, MA) (52). The dideoxy
sequencing reactions were performed as per the manufacturer's directions. Sequencing gels were run on a Genomyx LR Programmable DNA
sequencing apparatus (Genomyx, Fullerton, CA) maintained at 65°C.
Sequence analyses were performed using the GCG software package
(Wisconsin software package version 10, Genetics Computer Group,
Madison, WI).
Northern blotting. A 1340-bp probe corresponding to the 5' region of cablin cDNA was labeled by random priming (52). The approximate size and tissue expression of cablin mRNA was determined by hybridization of the radioactive probe to a multiple tissue Northern blot (Clontech, Palo Alto, CA) loaded with 2 µg of poly(A)+ mRNA per lane using ExpressHyb solution (Clonetech) and following the manufacturer's recommended protocol. As a control for RNA loading, the same blot was subsequently probed with a 1200-bp probe for rat glyceraldehyde-3-phosphate dehydrogenase (18).
Recombinant protein expression and purification. The cablin cDNA insert was subcloned into pET21b (Novagen, Madison, WI) and used to express the encoded protein in E. coli strain BL-21/DE3 (Stratagene) (58). The detergent-insoluble material remaining after bacterial lysis was solubilized in 8 M urea for 1 h at room temperature and dialyzed successively against six changes of 50 mM Tris · HCl, pH 8.0, 50 mM NaCl, and 1 mM EDTA containing decreasing concentrations of urea. The dialysate was assayed for purity by SDS-PAGE followed by Coomassie stain, and the pure protein was diluted in phosphate-buffered saline (PBS) and injected (200 µg/injection) into rabbits for antibody production (Covance, Denver, PA). Freund's complete adjuvant was used for the primary injection, and Freund's incomplete adjuvant was used for all subsequent booster injections.
Affinity purification of antibodies. Recombinant protein was dialyzed against two changes of PBS and coupled to Affigel-10 resin according to manufacturer's directions. Immune rabbit serum was bound to the resin-bound antigen and specific antibodies eluted from the column using standard procedures (25).
Cell culture and extract preparation. Normal human aortic smooth muscle cells, human lung microvascular endothelial cells, and human umbilical cord vein endothelial cells and their defined media were purchased from Clonetics (San Diego, CA). Cells were seeded at 3,500 cells/cm2 and allowed to grow to confluence over 3 days in a humidified atmosphere of 5% CO2 at 37°C. Serum-free medium was added to confluent cultures and collected after 18 h. Medium from one 35-mm dish was concentrated 10-fold and mixed with SDS-PAGE sample buffer containing dithiothreitol. Cells were rinsed briefly in PBS, scraped from the dish, and pelleted by centrifugation at 700 g for 5 min. The cell pellet was resuspended in sample buffer, sonicated for 30 s, and boiled for 5 min before being loaded onto gels.
Preparation of tissue extracts. A
0.5-g sample of normal human kidney cortex was thawed from
80°C and minced on ice. The tissue was further homogenized
in 15 mM Tris · HCl, pH 8.0, and 1 µM AEBSF with a
Tissue Tearor (BioSpec Products, Bartlesville, OK) until completely
liquefied. The homogenate was clarified by centrifugation for 10 min at
10,000 g at 4°C. The pellet
fraction was resuspended in 5 ml of 10 mM Tris · HCl,
pH 8.0, 2% SDS, 2% TX100, 10 mM EDTA, 0.5 M NaCl, 50 mM
dithiothreitol, 1 µM AEBSF, and 1 µM CLAP (chymostatin, leupeptin,
antipain, and pepstatin A), and incubated at 4°C for 8 h while
being rocked. The extracted pellet was again subjected to
centrifugation, and the resulting supernatant fraction was filtered
through a 0.4-µm syringe filter, SDS-PAGE sample buffer was added,
and the fraction was treated with 63 mM iodoacetamide (added as a
solid) for 30 min at room temperature in the dark.
SDS-PAGE and Western blot analysis. Proteins were separated on 10% SDS-PAGE gels. After electrophoresis, gels were transferred to nitrocellulose membranes. Nonspecific binding sites on immunoblots were blocked by a 1-h incubation period at room temperature with 0.5% nonfat dried milk in TBS-T. Blots were probed with 1 µg/ml of primary antibody (in some cases preincubated with a 10-fold molar excess of immunogen) followed by 1 µg/ml of HRP-conjugated secondary antibodies. Bound HRP-conjugated antibodies were detected using SuperSignal ECL reagent. Control blots were probed with preimmune serum and never gave any signal.
Angiogenesis model. Hypoxia-induced neovascularization was incited by following established experimental procedures (56). Briefly, mice were placed in a hyperoxic environment of 75% oxygen from postnatal days 7-12. From postnatal days 12-17 mice were returned to atmospheric oxygen (a hypoxic environment relative to 75% oxygen), after which time they were euthanized. Eyes were enucleated, embedded in OCT compound, and 10-µm frozen sections cut for immunohistochemical analysis.
Immunofluorescence microscopy. Unfixed frozen tissue sections embedded in OCT were cut (5-10 µm in thickness) and collected on Probe-On Plus microscope slides (Fisher Scientific, Chicago, IL). Sections were blocked with PBS containing 0.2% cold water fish skin gelatin for 30 min at room temperature before incubation with antibodies. Sections were incubated with either affinity-purified antibodies, immune serum, or preimmune serum at a concentration of 10 µg/ml for 1 h at 37°C. Primary antibodies were detected with FITC- or rhodamine-conjugated goat anti-rabbit IgG or goat anti-mouse IgG (20 µg/ml), and sections were mounted in Mowiol 4-88 or Vectashield-DAPI (Vector, Burlingame, CA). No signal was observed in sections stained with preimmune serum. Images were collected using an inverted Zeiss LSM 410 or Biorad MRC600, both equipped with He-Ne and Ar-Kr lasers.
Histological staining. Sections were stained with Mayer's hematoxylin and counter-stained with eosin (Sigma) according to manufacturer's instructions. Elastic fibers in bovine mitral valve wall were visualized by staining sections with a 1/10 aqueous solution of India ink for 3 min, followed by extensive rinsing with water.
Immunoelectron microscopy. A normal kidney from a Sprague-Dawley male rat was excised immediately after decapitation and chopped into 0.5-mm2 pieces in 0.1 M sodium cacodylate, 2.5% glutaraldehyde, 2% paraformaldehyde, and incubated in this fixative for 2 h at room temperature. Reactive aldehyde groups were quenched with 50 mM ammonium chloride in 0.1 M sodium cacodylate for 30 min at room temperature. The tissue was then extracted for 30 min at room temperature with 0.1% saponin in 0.1 M sodium cacodylate then rinsed briefly in this buffer alone. The tissue was dehydrated by successive incubations (5 min each at room temperature) in 10%, 30%, and 50% ethanol followed by two incubations (30 min each at room temperature) in 70% ethanol. The minced pieces were embedded in LR White resin according to manufacturer's instructions. Sections (60- to 70-nm-thick) were cut from the polymerized blocks and collected on Formvar-coated nickel grids. Sections were immunolabelled by floating them upside down on drops of primary antibody diluted to 10 µg/ml in PBS containing 0.2% cold water fish skin gelatin for 1 h at room temperature, rinsing several times in PBS, and incubating for 30 min at room temperature with 20-nm gold-conjugated goat anti-rabbit IgG diluted 1/50 in PBS, 0.2% fish skin gelatin. Rinsed sections were then contrasted sequentially with uranyl acetate and lead citrate. Immunogold decoration was not evident when sections were incubated with preimmune serum. Images were collected using a Hitachi H-600 transmission electron microscope.
| |
RESULTS |
|---|
|
|
|---|
Isolation and characterization of a cDNA clone
encoding a novel protein. The screening of an
oligo(dT)-primed human placental expression cDNA library with an
antibody directed against a unique peptide (see
MATERIALS AND METHODS) resulted in
four independent isolates, termed c4, containing identical 1.742-kb
inserts. The nucleotide and deduced amino acid sequences (Fig.
1A)
encoded by the 1.742-kb cDNA were found to represent a previously
uncharacterized molecule based on searches of both nucleotide and
protein databases. Evident in the sequence was a single, long, open
reading frame of 270 amino acids, a polyadenylation signal (AATAAA),
and a poly(A) tail. The lack of a consensus sequence for translation
initiation (31) suggested that c4 most likely encoded the carboxy
terminus of a novel protein. Searches of both the expressed sequence
tag database and nonredundant nucleotide databases identified several entries matching the sequence of c4, but none provided any additional 5' sequence information.
|
Both the deduced amino acid composition and primary structure of the c4
protein indicate that it is likely to be an
-helical molecule (Fig.
1). The predominance of glutamic acid, alanine, and leucine residues
found throughout the c4 protein (Fig.
1A) is not unusual in
-helical
proteins. Appropriate spacing of charged and polar side chains lends
stability to
-helices through the formation of salt bridges (35),
whereas alanine residues often constitute the hydrophobic face of
helices (4, 36). Structure prediction algorithms configured the c4
protein into two long
-helical regions separated by turns (Fig.
1B). Contained within the protein is
a 60 amino acid sequence with 22% homology to a microfibrillar
elastin-binding peptide (underlined in Fig.
1A) (44). Also apparent is the
tripeptide sequence RGD, known to mediate binding to the integrin
family of cell adhesion molecules (bold letters in Fig.
1A). The carboxy terminus of the
protein contains numerous prolines and is expected to form a rigid tail on the end of this predicted helical molecule. The absence of a
contiguous stretch of hydrophobic amino acids suggests that the c4
protein lacks a membrane-spanning domain.
Comparison of the deduced amino acid sequence to known proteins
revealed significant homologies to several structural proteins possessing
-helical and coiled-coil domains. Among those with over
20% identity were the hemidesmosomal protein plectin, the bacterial
import protein TolA, protein A kinase anchoring protein, and nonmuscle
myosin heavy chain II. Without exception, homology with the c4 protein
was limited to the glutamic acid-alanine-leucine-rich
-helical
domains of these proteins, implying that these primary amino acid
sequences mediate folding into similar domains in functionally diverse
proteins. These data are suggestive that the c4 protein exists as a
rod-shaped or coiled-coil molecule.
Tissue-specific expression of the full-length c4
transcript. The distribution of the full-length c4
transcript in a panel of human tissues was determined by Northern blot
analysis (Fig. 2). A c4 probe hybridized
with a single transcript of ~2.5 kb in all tissues tested. The
message was most abundant in placenta (Pl), pancreas (Pa), kidney (K),
and skeletal muscle (M), whereas little was detected in the brain (B).
Moderate expression was detected in the heart (H). These data indicate
that c4 encodes a protein, which is expressed in a variety of tissue
types. A probe for glyceraldehyde-3-phosphate dehydrogenase was used as a control for RNA loading and as expected a transcript of 1.26 kb was
detected in all lanes but was most abundant in heart and skeletal
muscle samples (Fig. 2, bottom
panel).
|
An 80,000-molecular weight protein is the product of
c4 in vivo. Western blot analysis was used to analyze
the molecular weight and the predicted tissue distribution of the
protein encoded by c4. Polyclonal antibodies generated against purified
recombinant protein encoded by c4 were used to probe an immunoblot of
normal human kidney tissue extracts (Fig.
3). Both the antiserum
(lane 1) and the affinity-purified
antibodies (lane 3) identified a protein of 80,000 molecular weight, whereas the preimmune serum (lane 2) and immune serum
preincubated with immunizing antigen (lane
4) failed to bind the immunoblot. Tissue extracts
from mitral valve wall and pancreas were also found to contain this
80,000-molecular weight protein (data not shown). Thus the polyclonal
antibody very specifically recognized an 80,000-molecular weight
protein in tissue extracts expressing the c4 transcript. Efforts were next focused on immunolocalization of the antigen in situ.
|
Localization of c4 protein to the
vasculature. Immunofluorescence microscopy was utilized
to examine the localization of the c4 protein in human kidney cortex,
bovine mitral valve wall, and rat pancreas. An abundance of the protein
was evidenced in the kidney cortex (Fig. 4,
A and
D), where it was specifically
limited to the glomeruli and small (4-15 µm diameter)
peritubular vessels (Fig. 4A, arrow;
see also Fig. 5). Examination of mitral valve wall, a relatively
homogeneous tissue consisting of the endothelium and vascular basement
membrane, revealed staining of discrete curvilinear fibers oriented
parallel to the direction of blood flow (Fig. 4,
B and
E). Furthermore, the immunostaining
in a section of pancreatic tissue enriched in elastic and muscular
vessels was also restricted to the vasculature (Fig. 4,
C and
F). These results demonstrated that
the c4 protein was expressed in the vasculature, predominantly in small
vessels.
|
Antibodies to the c4 protein specifically stain
microvascular elements. Double immunofluorescence
studies were employed to definitively identify the vascular elements
with which the 80,000-molecular weight protein was preferentially
associated. Monoclonal antibody A028, directed against an unspecified
endothelial cell surface protein, was used to visualize all vascular
structures. Immunostaining of kidney tissue with this antibody in
conjunction with the polyclonal antibody directed against the c4
protein revealed that c4 protein was associated with a subset of
vascular elements (Fig.
5A).
Both the glomerular capillaries as well as peritubular capillaries were
positive for the c4 protein, and fortuitous oblique sections revealed
staining of the juxtaglomerular mesangial matrix (data not
shown). Interstitial tissue and renal tubules were devoid of
immunoreactivity. At slightly higher magnification, overlap between the
antigens in a subset of vessels was more readily apparent (Fig.
5B). Notably, a significant
population of vessels was not stained with the antibodies directed
against the c4 protein. These findings were corroborated in
double-labeling experiments using antibodies directed against the
circulating coagulatory protein von Willebrand factor as a marker for
endothelia (data not shown).
|
The observation that c4 protein was associated with a limited
population of blood vessels spurred an examination of the relative abundance of the protein in artery versus small periarterial vessels. Immunofluorescence microscopy of mesenteric artery in cross section revealed a modest deposition of the c4 protein in fibrillar arrays throughout the vascular wall of the artery. However, in sections where
small periarterial vessels were also present, it was evident that the
c4 protein was markedly enriched in these vessels (Fig. 6, A and
B). Together these data suggested
that expression of c4 protein was most prevalent in the
microvasculature. In addition, the fibrillar arrangement of the c4
protein evident in large vessels indicated it may be a component of the
extracellular matrix.
|
c4 Protein is deposited in the basal laminae of
capillaries. Immunoelectron microscopic analysis of
kidney tissue was instrumental in establishing the precise spatial
relationship between microvascular endothelial cells and the c4
protein. A low-magnification micrograph of a peritubular capillary in
which the vessel lumen, an endothelial cell, the basal lamina, and a
periendothelial cell are evident demonstrated an association of c4
protein with the capillary basal lamina (Fig.
7A,
arrows). A higher magnification view of a similar section features the
basal lamina encapsulating an endothelial cell and the process of a
periendothelial cell (Fig. 7B). Gold particles decorated c4 protein throughout the extracellular matrix, notably among fibrillar material. To facilitate visualization of gold
labeling, a detection antibody conjugated to large gold (20 nm) was
used, which may account for the somewhat sparse labeling observed. The
association of c4 protein with the fibrillar matrix surrounding
capillaries prompted us to name the protein cablin (protein of the
capillary basal lamina).
|
Cellular expression and secretion of
cablin. The close apposition between sites of cablin
deposition and endothelial and periendothelial cells suggested that one
or both of these cell types might be responsible for its biosynthesis.
Cellular extracts and conditioned media of primary cells in culture
were therefore tested for cablin expression by immunoblot analysis.
Cablin was synthesized and secreted by all cell types examined,
including vein endothelial cells, microvascular endothelial cells, and
aortic smooth muscle cells (Fig. 8,
A and
B, arrow). (A slightly lower molecular
weight band, seen in Fig. 8A, is
thought to represent a degradation intermediate.) However, the extent
of cablin secretion by different cell types was particularly
noteworthy. Smooth muscle cells produced significant amounts of cablin
(Fig. 8A), yet secretion appeared to
be inefficient. Endothelial cells synthesized less cablin, but the
majority of the protein was secreted (Fig.
8B). On the basis of these in vitro data it is plausible that relative to other cell types endothelial cells may preferentially deposit cablin in vascular extracellular matrices.
|
Cablin is expressed at sites of
angiogenesis. The deposition of cablin in microvascular
basal laminae prompted us to examine its expression in capillaries
undergoing angiogenesis. In a murine model of retinal
neovascularization (56), hypoxia-induced stress results in
proliferation and migration of endothelial cells normally present only
in a discrete vascular layer at the periphery of the retina. This
response leads to the formation of angiogenic tufts that invade the
vitreous. Immunofluorescence microscopic analysis of control retinas
revealed that cablin colocalized with an endothelial cell marker (Fig.
9B, arrowhead) in
the vascular layer along the outer retina (Fig.
9A, asterisk). Weak cablin staining
could be detected in the cell layer immediately above the photoreceptor
cells, but this was barely above a diffuse background signal also
observed with preimmune serum (Fig.
9E). Neither endothelial cells nor
cablin were detected in the layer abutting the vitreous (containing the
optic nerve fibers). In contrast to control retinas, those recovered
following hypoxia displayed capillary tufts consisting of 5-10
endothelial cells growing into the vitreous (Fig.
9C, arrow), and endothelial cells were
seen to permeate all layers of the retina. Although cablin was apparent
in the tufts themselves (Fig. 9D,
arrows), the predominant immunoreactive regions were immediately
subjacent to the tufts. This finding raises the possibility that
recruitment of endothelial cells to sites of hypoxic injury is
correlated with the induction of cablin expression and its assembly
into a supporting extracellular matrix.
|
| |
DISCUSSION |
|---|
|
|
|---|
This study describes the characterization of cablin, a novel protein
preferentially associated with the capillary basal lamina. The protein
was synthesized and secreted by cultured microvascular endothelial
cells as well as vascular smooth muscle cells, hypothesized to be
differentiated pericytes (37, 39, 48, 49). In addition, its synthesis
was upregulated in tissue undergoing active neovascularization. Cablin
was predominantly associated with the microvasculature, where it was
specifically arrayed in the electron-lucent amorphous material of
capillary basal laminae. These findings offer the first indication that
the microvascular basal lamina is biochemically unique. Analyses of
amino acid sequence composition and predicted secondary structure are
consistent with cablin being an
-helical, rodlike protein with
domains characteristic of extracellular matrix proteins. The enrichment
of cablin in vascular regions subject to high hydrostatic pressure and
shear force (including the glomerular basement membrane and the
juxtaglomerular mesangial matrix), in conjunction with a possible
association with microfibrils, suggest that cablin reinforces the
architectural integrity of the tissue.
The microvasculature consists of networks of capillaries, precapillary arterioles, and postcapillary venules highly specialized for the fundamental activities of molecular exchange and angiogenesis. Results presented here demonstrated that cablin was predominantly associated with the microvasculature and minimally with other vessels. Immunodetection of cablin was predicated on the relative abundance of capillaries within the sample. The glomerular and peritubular microvasculature within the microvessel-rich kidney cortex were the exclusive sites of cablin immunoreactivity. However, examination of sections enriched in elastic and muscular vessels revealed that these structures were in fact immunoreactive, albeit to a lesser extent than capillaries. Here, low levels of cablin were apparent in discrete fibrillar arrays interspersed between elastin fibrils. Although tissue etching has been instrumental in revealing masked antigenic sites on extracellular matrix proteins (22), this procedure did not alter the unprecedented distribution of cablin to a subset of vascular elements (data not shown).
The vasculature represents a continuum of vessel segments that are functionally and morphologically distinct on account of transitions in cellular phenotype. Therefore, vascular cells from diverse vessel populations were screened for cablin synthesis. Because of the difficulties associated with isolation and cultivation of pericytes, these cells could not be examined directly. However, on the basis of biochemical and morphological studies, several groups have hypothesized that pericytes differentiate into vascular smooth muscle cells (37, 39, 48, 49). Interestingly, when vascular smooth muscle cells were screened for cablin production, they were found to synthesize the greatest amount of protein among the cell types analyzed. However, microvascular endothelial cells secreted the most cablin. Therefore, it is likely that pericytes, analogous to vascular smooth muscle cells, contribute some cablin to the capillary basal lamina, but the microvascular endothelial cells are principally responsible for its deposition. Although the cellular composition of capillaries has long been recognized as unique, these data offer the first indication that the biochemical constitution of capillary basal laminae is also distinct.
The primary amino acid sequence of cablin contains two domains
implicated in cell and extracellular matrix binding: an
integrin-binding RGD motif and a putative elastin-binding sequence. The
RGD tripeptide mediates the binding of extracellular matrix components
to cellular integrins (29). RGD-binding integrins found in vascular
tissue include
3
1 and
5
1. Notably, capillary endothelial
cells are the only vascular cells that express
5
1 integrins
beyond embryogenesis (41). Potential interactions between cablin and
the
5
1 integrin may stabilize cell-extracellular matrix adherence
while potentiating signaling cascades. These possibilities are
currently being explored.
The second identifiable domain in cablin was a 60 amino acid stretch containing 22% identity with a bacterial elastin-binding peptide (44). Compellingly, cablin was detected in the electron-lucent regions of the basal lamina bearing resemblance to sites of elastin-associated microfibril deposition (7, 24), where it appeared in close apposition to fibrous structures. The possible association of cablin with microfibrils is particularly intriguing given the organization of microfibrils into a mechanically dynamic molecular scaffold on which effector molecules are assembled.
Because of the extensive cross-linking and organization within the
extracellular matrix, microfibril proteins are notoriously difficult to
remove from tissue. Sequential tissue extraction revealed the release
of cablin in two pools (data not shown). Mild extraction conditions,
including low levels of nonionic detergent, removed a portion of
cablin, whereas the remainder of the protein was only extracted by
harsh, reductive saline conditions. Cablin extracted under the mild
conditions may represent a cellular or soluble extracellular form of
the protein. The pool recovered on harsh extraction may correspond to
molecules embedded in the extracellular matrix. Analogous
solubilization conditions were necessary to disrupt the association
between other secreted molecules (such as latent TGF-
binding
proteins and thrombospondin) and microfibrils (3, 21). On the basis of
these morphological and biochemical analyses, the deposition or
adsorption of cablin to microfibrils or other components of the
extracellular matrix seems likely.
Capillaries serve a unique role in both angiogenesis and metabolite exchange. Detailed morphological studies have demonstrated that the architecture of the microvasculature is uniquely adapted for these functions. The structure and differentiation of the tissue is in turn dependent on the molecular composition and organization of the extracellular matrix. It is envisaged that as a unique component of the capillary matrix, cablin could function in either a structural or regulatory capacity. As a putative structural component of elastin-containing microfibrils, cablin may be important in the resistance of the tissue against mechanical injury. Such a scenario is supported by the localization of cablin to regions of high hydrostatic pressure, the extraction properties of cablin, and the likely association of cablin with components essential for structural integrity. However, it is also important to consider that angiogenic cell proliferation, differentiation, and migration are governed by the composition of this extracellular matrix (17, 26, 28, 32). Capillary sprouts are surrounded by discrete areas of extracellular matrix reorganization and synthesis (13). Therefore, the observation that cablin synthesis is induced during neovascularization is quite compelling. Conceivably, cablin could provide differentiation cues or scaffolding critical for endothelial migration during angiogenesis. Because angiogenesis is necessary for disease processes such as tumor progression and diabetic retinopathy, it is possible that regulation of cablin expression may influence the angiogenic potential of tissues involved in pathological processes. Elucidation of possible structural or regulatory roles of cablin, the first unique component of the capillary basal lamina, is likely to contribute to the understanding of processes unique to the microvasculature.
| |
ACKNOWLEDGEMENTS |
|---|
This study is the result of collaborative efforts between A. Wandinger-Ness and R. L. Bacallao, who contributed equally to the supervision of the experiments herein.
| |
FOOTNOTES |
|---|
We thank Eugene Minner for preparing ultrathin tissue sections. Drs. Paul McGuire and Nancy Kanagy graciously provided sections of retinas and mesenteric artery, respectively. Dr. Richard Larson and David Brown supplied valuable cell cultures. We also thank Drs. Nancy Kanagy and Richard Larson for critically reading the paper.
This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Grants R01 DK-50141 (to A. Wandinger-Ness) and R29 DK-46883 to (R. L. Bacallao). A. Wandinger-Ness is the recipient of start-up funds provided by a Howard Hughes Medical Institute Research Resources for Medical Schools Award (76296-550501). A. J. Charron was partially supported by a National Institutes of Health Predoctoral Training Grant T32 GM-08061.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: A. Wandinger-Ness, Dept. of Pathology, CRF 225, 2325 Camino de Salud, Univ. of New Mexico Health Sciences Center, Albuquerque, NM 87131 (E-mail: wness{at}unm.edu).
Received 12 April 1999; accepted in final form 14 June 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adams, R. H.,
G. A. Wilkinson,
C. Weiss,
F. Diella,
N. W. Gale,
U. Deutsch,
W. Risau,
and
R. Klein.
Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.
Genes Dev.
13:
295-306,
1999
2.
Albelda, S. M.,
and
C. A. Buck.
Integrins and other cell adhesion molecules.
FASEB J.
4:
2868-2880,
1990[Abstract].
3.
Arbeille, B. B.,
F. M. J. Fauvel-Lafeve,
M. B. Lemesle,
D. Tenza,
and
Y. J. Legrand.
Thrombospondin: a component of microfibrils in various tissues.
J. Histochem. Cytochem.
39:
1367-1375,
1991[Abstract].
4.
Branden, C.,
and
J. Tooze.
Introduction to Protein Structure. New York: Garland, 1991.
5.
Bressan, G. M.,
D. Daga-Gordini,
A. Colombatti,
I. Castellani,
V. Marigo,
and
D. Volpin.
Emilin, a component of elastic fibers preferentially located at the elastin-microfibrils interface.
J. Cell Biol.
121:
201-212,
1993
6.
Bruns, R. R.,
and
G. E. Palade.
Studies on blood capillaries. I. General organization of blood capillaries in muscle.
J. Cell Biol.
37:
244-276,
1968
7.
Cleary, E. G.,
and
M. A. Gibson.
Elastin-associated microfibrils and microfibrillar proteins.
Int. Rev. Connect. Tissue Res.
10:
97-209,
1983[Medline].
8.
Cohen, M. P.,
R. N. Frank,
and
A. A. Khalifa.
Collagen production by cultured retinal capillary pericytes.
Invest. Ophthalmol. Vis. Sci.
19:
90-94,
1980
9.
Courtoy, P. J.,
and
J. Boyles.
Fibronectin in the microvasculature: localization in the pericyte-endothelial interstitium.
J. Ultrastruct. Res.
83:
258-273,
1983[Medline].
10.
Courtoy, P. J.,
Y. S. Kanwar,
R. O. Hynes,
and
M. G. Farquhar.
Fibronectin localization in the rat glomerulus.
J. Cell Biol.
87:
691-696,
1980
11.
Courtoy, P. J.,
R. Timpl,
and
M. G. Farquhar.
Comparative distribution of fibronectin, type IV collagen, and laminin in the rat glomerulus.
J. Histochem. Cytochem.
30:
874-886,
1982[Abstract].
12.
Dietz, H. C.,
G. R. Cutting,
R. E. Pyeritz,
C. L. Maslen,
L. Y. Sakai,
G. M. Corson,
E. G. Puffenberger,
A. Hamosh,
E. J. Nanthakumar,
S. M. Curristin,
G. Stetten,
D. A. Meyers,
and
C. A. Francomano.
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.
Nature
352:
337-339,
1991[Medline].
13.
Ekblom, P.
Formation of basement membranes in the embryonic kidney: an immunohistochemical study.
J. Cell Biol.
91:
1-10,
1981
14.
Farquhar, M. G.,
S. L. Wissig,
and
G. E. Palade.
Glomerular permeability: I. Ferritin transfer across the normal capillary wall.
J. Exp. Med.
113:
47-66,
1961[Abstract].
15.
Fawcett, D. W.
The fine structure of capillaries, arterioles, and small arteries.
In: The Microcirculation, edited by S. R. M. Reynolds,
and B. Zweifach. Urbanai: University of Illinois Press, 1959.
16.
Folkman, J.,
M. Klagsbrun,
J. Sasse,
M. Wadzinski,
D. Inger,
and
I. Vlodavsky.
A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane.
Am. J. Pathol.
130:
393-399,
1988[Abstract].
17.
Form, D. M.,
B. M. Pratt,
and
J. A. Madri.
Endothelial cell proliferation during angiogenesis. In vitro modulation by basement membrane components.
Lab. Invest.
55:
521-530,
1986[Medline].
18.
Fort, P.,
L. Marty,
M. Piechaczyk,
S. el Sabrouty,
C. Dani,
P. Jeanteur,
and
J. M. Blanchard.
Various rat adult tissues express only one major mRNA species from the glyceraldeyde-3-phosphate-dehydrogenase muligenic family.
Nucleic Acids Res.
11:
1431-1442,
1985.
19.
Fujiwara, T.,
and
Y. Uehara.
The cytoarchitecture of the wall and the innervation pattern of the microvessels in the rat mammary gland: a scanning electron microscopic observation.
Am. J. Anat.
170:
39-54,
1984[Medline].
20.
Gamse, G., H. G. Fromme, and H. Kresse. Metabolism
of sulfated glycosaminoglycans in cultured endothelial cells and smooth
muscle cells from bovine aorta. Biochim. Biophys.
Acta: 514-528, 1978.
21.
Gibson, M. A.,
G. Hatzinikolas,
E. C. Davis,
E. Baker,
G. R. Sutherland,
and
R. P. Mecham.
Bovine latent transforming growth factor beta 1-binding protein 2: Molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils.
Mol. Cell. Biol.
15:
6932-6942,
1995[Abstract].
22.
Gibson, M. A.,
J. S. Kumaratilake,
and
E. G. Cleary.
The protein components of the 12-nanometer microfibrils of elastic and non-elastic tissues.
J. Biol. Chem.
264:
4590-4598,
1989
23.
Gospodarowicz, D.,
G. Greenburg,
J.-M. Foidart,
and
N. Savion.
The production and localisation of laminin in cultured vascular and corneal endothelial cells.
J. Cell. Physiol.
107:
171-183,
1981[Medline].
24.
Greenlee, T. K.,
R. Ross,
and
J. L. Hartman.
The fine structure of elastic fibers.
J. Cell Biol.
30:
59-71,
1966
25.
Harlow, E.,
and
D. Lane.
Antibodies. A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Press, 1988.
26.
Hedin, U.,
B. A. Bottger,
E. Forsberg,
S. Johannson,
and
J. Thyberg.
Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells.
J. Cell Biol.
107:
307-319,
1988
27.
Heifetz, A.,
and
D. Allen.
Biosynthesis of cell surface sulphated glycoproteins by cultured vascular endothelial cells.
Biochemistry
21:
171-177,
1982[Medline].
28.
Herbst, T. J.,
J. B. McCarthy,
E. C. Tsilibary,
and
L. T. Furcht.
Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration.
J. Cell Biol.
106:
1365-1373,
1988
29.
Hynes, R. O.
Integrins: Versatility, modulation, and signaling in cell adhesion.
Cell
69:
11-25,
1992[Medline].
30.
Jaffe, E. A.,
and
D. F. Mosher.
Synthesis of fibronectin by cultured human endothelial cells.
J. Exp. Med.
147:
177-179,
1978.
31.
Kozak, M.
An analysis of vertebrate mRNA sequences: intimations of translational control.
J. Cell Biol.
115:
887-903,
1991
32.
Kubota, Y.,
H. K. Kleinman,
G. R. Martin,
and
T. J. Lawley.
Role of laminin and basement membrane in the morphological differentiation of human endothelial cells in capillary-like structures.
J. Cell Biol.
107:
1589-1598,
1988
33.
Kumaratilake, J. S.,
M. Gibson,
J. C. Fanning,
and
E. G. Cleary.
The tissue distribution of microfibrils reacting with a monospecific antibody to MAGP, the major glycoprotein antigen of elastin-associated microfibrils.
Eur. J. Cell Biol.
50:
117-127,
1989[Medline].
34.
Low, F. N.
Microfibrils: fine filamentous components of the tissue space.
Anat. Rec.
142:
131-137,
1962.
35.
Marqusee, S.,
and
R. L. Baldwin.
Helix stabilization by Glu-Lys- salt bridges in short peptides of de novo design.
Proc. Natl. Acad. Sci. USA
84:
8898-8902,
1987
36.
Marqusee, S.,
V. H. Robbins,
and
R. L. Baldwin.
Unusually stable helix formation in short alanine-based peptides.
Proc. Natl. Acad. Sci. USA
86:
5286-5290,
1989
37.
Meyrick, B.,
K. Fujiwara,
and
L. Reid.
Smooth muscle myosin in precursor and mature smooth muscle cells in normal pulmonary arteries and the effect of hypoxia.
Exp. Lung Res.
2:
303-313,
1981[Medline].
38.
Moren, A.,
A. Olofsson,
G. Stenman,
P. Sahlin,
T. Kanzaki,
L. Claesson-Welch,
P. ten Dijke,
K. Miyazono,
and
C. Heldin.
Identification and characterization of LTBP-2, a novel latent transforming growth factor beta-binding protein.
J. Biol. Chem.
269:
32469-32478,
1994
39.
Movat, H. S.,
and
N. V. P. Fernando.
The fine structure of the terminal vascular bed. IV. The venules and their perivascular cells (pericyte, adventitial cells).
Exp. Mol. Pathol.
3:
98-114,
1964.
40.
Mundel, P.,
M. Elger,
T. Sakai,
and
W. Kritz.
Microfibrils are the major component of the mesangial matrix of the glomerulus of the rat kidney.
Cell Tissue Res.
254:
183-187,
1988[Medline].
41.
Muschler, J. L.,
and
A. F. Horwitz.
Down-regulation of the chicken alpha 5 beta 1 integrin fibronectin receptor during development.
Development
113:
327-337,
1991[Abstract].
42.
Nakajima, Y.,
K. Miyazono,
M. Kato,
M. Takase,
T. Yamagishi,
and
H. Nakamura.
Extracellular fibrillar structure of latent TGF beta binding protein-1: Role in TGF beta-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart.
J. Cell Biol.
136:
193-204,
1997
43.
Palade, G. E.
Blood capillaries of the heart and other organs.
Circulation
24:
368-384,
1961
44.
Park, P. W.,
J. Rosenbloom,
W. R. Abrams,
J. Rosenbloom,
and
R. P. Mecham.
Molecular cloning and expression of the gene for elastin-binding protein (ebpS) in Staphylococcus aureus.
J. Biol. Chem.
271:
15803-15809,
1996
45.
Putnam, E. A.,
H. Zhang,
F. Ramirez,
and
D. M. Milewicz.
Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly.
Nat. Genet.
11:
456-458,
1995[Medline].
46.
Rhodin, J. A. G.
The ultrastructure of mammalian arterioles and precapillary sphincters.
J. Ultrastruct. Res.
18:
181-223,
1967[Medline].
47.
Rhodin, J. A. G.
Architecture of the vessel wall.
In: Handbook of Physiology. The Cardiovascular System. Vascular Smooth Muscle. Bethesda, MD: Am. Physiol. Soc., 1980, sect. 2, vol. II, chapt. 1, p. 1-31.
48.
Rhodin, J. A. G.
Ultrastructure of mammalian venous capillaries, venules, and small collecting veins.
J. Ultrastruct. Res.
25:
452-500,
1968[Medline].
49.
Rhodin, J. A. G.,
and
H. Fujita.
Capillary growth in the mesentery of normal young rats. Intravital video and electron microscope analysis.
J. Submicrosc. Cytol. Pathol.
21:
1-34,
1989[Medline].
50.
Risau, W.
Mechanisms of angiogenesis.
Nature
386:
671-674,
1997[Medline].
51.
Risau, W.
Vasculogenesis, angiogenesis, and endothelial cell differentiation during embryonic development.
In: Issues in Biomedicine: The Development of the Vascular System, edited by R. N. Feinberg,
G. K. Sherer,
and R. Auerbach. Basel: Karger, 1991.
52.
Sambrook, J.,
E. F. Fritsch,
and
T. Maniatis.
Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
53.
Sariola, H.
Interspecies chimeras: an experimental approach for studies on embryonic angiogenesis.
Med. Biol. Eng.
63:
43-65,
1985.
54.
Sariola, H.
Mechanisms and regulation of the vascular growth during kidney differentiation.
In: Issues in Biomedicine: The Development of the Vascular System, edited by R. N. Feinberg,
G. K. Sherer,
and R. Auerbach. Basel: Karger, 1991.
55.
Sariola, H.,
R. Timpl,
K. von der Mark,
R. Mayne,
J. M. Fitch,
T. F. Linsenmayer,
and
P. Ekblom.
Dual origin of glomerular basement membrane.
Dev. Biol.
101:
86-96,
1984[Medline].
56.
Smith, L. E. H.,
E. Wesolowski,
A. McLellan,
S. K. Kostyk,
R. D'Amato,
R. Sullivan,
and
P. A. D'Amore.
Oxygen-induced retinopathy in the mouse.
Invest. Ophthalmol. Vis. Sci.
35:
101-111,
1994
57.
Stramm, L. E.,
W. Li,
G. D. Aguirre,
and
J. H. Rockey.
Glycosaminoglycan synthesis and secretion by bovine retinal capillary pericytes in culture.
Exp. Eye Res.
44:
17-28,
1987[Medline].
58.
Studier, F. W.,
and
B. A. Moffatt.
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.
J. Mol. Biol.
189:
113-130,
1986[Medline].
59.
Wang, H. U.,
Z. Chen,
and
D. J. Anderson.
Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.
Cell
93:
741-753,
1998[Medline].
This article has been cited by other articles:
![]() |
E. C. Leonard, J. L. Friedrich, and D. P. Basile VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1648 - F1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Horbelt, S.-Y. Lee, H. E. Mang, N. L. Knipe, Y. Sado, A. Kribben, and T. A. Sutton Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury Am J Physiol Renal Physiol, September 1, 2007; 293(3): F688 - F695. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |